Cannabis Watch

Investing

Home
Cannabis Watch

New York cannabis board OK’s settlement in licensing suit brought by veterans

‘It’s very easy to get fooled’: Two cannabis rivals are raising awareness about fake-products scams

Canopy Growth hits snag with SEC over Canopy USA plan

Cresco Labs’ stock rises as revenue beats analyst estimate

Canopy Growth’s cash burn raises analyst concerns

Curaleaf and Canopy Growth miss third-quarter analyst marks while Green Thumb, Ascend Wellness, TerrAscend and Trulieve beat forecasts

Ticker	Name	Last	Chg	Chg %
ACB	Aurora Cannabis Inc.	$0.63	0.01	1.61%
CRON	Cronos Group Inc.	$2.83	0.07	2.54%
WEED	Canopy Growth Corp.	$0.83	0.08	10.67%
TLRY	Tilray Brands Inc.	$1.9000	0.0900	4.97%

What happens if a husband names someone other than his wife the beneficiary of an IRA?

Uber is officially an adult company, in large part due to CEO Dara Khosrowshahi

My father has dementia and ‘forgave’ my brother’s $200,000 house loan. The nursing-home notary said he was of sound mind. What can we do?

How to (legally) avoid taxes when selling a house

Dow near record high because traders are calling bluff on ‘higher-for-longer’ Fed

Gold futures soar to record close. Here’s what’s driving the rally.

Will George Santos still qualify for a pension and strolling around the House floor?

I was ‘financially set’ after my husband died. But my current adviser lost $500,000 over the last few years, and then a new adviser said my portfolio was ‘a mess’ and wants 1.25% to fix it. What’s my move?

Pimco's bond chief says investors need to prepare for a hard landing

My husband added my mother-in-law to the deed of our house 20 years ago. Now we’re getting divorced, and she wants one-third. Can I fight this?

Bettering Co. takes aim at New York and New Jersey with premium edibles as legal-cannabis market grows slowly

0.65%

Nov. 10, 2023 at 7:42 a.m. ET by Steve Gelsi

Americans’ support for legalizing cannabis edges up to 70% and Ohio voters OK pot referendum, as cannabis stocks rise

TCNNF

0.04%

Nov. 8, 2023 at 4:12 p.m. ET by Steve Gelsi

Organigram’s stock soars as British American Tobacco invests $91.3 million

OGI

4.69%

Nov. 6, 2023 at 1:03 p.m. ET by Ciara Linnane

Ohio voters could legalize marijuana use next week, polls show

TYL

1.20%

Nov. 1, 2023 at 1:06 p.m. ET by Steve Gelsi

Cannabis companies hire Microsoft antitrust lawyer David Boies to sue U.S. government for federal pot prohibition

GTBIF

0.52%

Oct. 27, 2023 at 11:38 a.m. ET by Steve Gelsi

Tilray’s net loss narrows as revenue climbs to record

TLRY

4.97%

Oct. 4, 2023 at 2:41 p.m. ET by Steve Gelsi

Glass House Brands charts contrarian course as ex-cop fights for release of cannabis convicts and eyes low-cost cultivation in California

GLASF

-0.21%

Oct. 3, 2023 at 2:17 p.m. ET by Steve Gelsi

Cannabis company Curaleaf applying to move listing to Toronto Stock Exchange in a move to boost visibility

CURLF

2.87%

Sep. 28, 2023 at 5:34 p.m. ET by Steve Gelsi

Cannabis stocks rise as Senate committee OKs cannabis banking bill

CURLF

2.87%

Sep. 27, 2023 at 12:05 p.m. ET by Steve Gelsi

Canopy Growth’s stock sustains rally as it draws praise for BioSteel exit

CGC

10.36%

Sep. 15, 2023 at 10:49 a.m. ET by Steve Gelsi

Canopy Growth’s BioSteel sports drink unit files for bankruptcy in a move to stem cash burn

CGC

10.36%

Sep. 14, 2023 at 10:57 a.m. ET by Steve Gelsi

Medical-cannabis companies blast New York for ‘clear course for failure’ in state pot-business rollout

CURLF

2.87%

Sep. 6, 2023 at 11:40 a.m. ET by Steve Gelsi

Raw rolling papers founder looks to further elevate cannabis name celebrated in Wiz Khalifa song

TPB

3.02%

Sep. 5, 2023 at 8:25 a.m. ET by Steve Gelsi

HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain

TLRY

4.97%

Aug. 31, 2023 at 10:40 a.m. ET by Steve Gelsi

HHS recommends rescheduling cannabis, and stocks in the sector rally

CGC

10.36%

Aug. 30, 2023 at 8:58 p.m. ET by Steve Gelsi

Canopy Growth selling Smiths Falls facility back to Hershey to generate about $39 million to pay down debt

CGC

10.36%

Aug. 17, 2023 at 8:43 a.m. ET by Steve Gelsi

TerrAscend says Morgan Stanley, BNY Mellon lift custody ban on cannabis for Toronto Stock Exchange listing

1.95%

Aug. 11, 2023 at 3:23 p.m. ET by Steve Gelsi

Corrected Canopy Growth beats analyst targets as its ‘asset-light’ strategy bears fruit, but Curaleaf’s miss weighs on pot stocks

CURLF

2.87%

Aug. 10, 2023 at 8:59 p.m. ET by Steve Gelsi

Cannabis company Tilray rallies as it narrows its loss on a 20% boost to revenue

TLRY

4.97%

Jul. 26, 2023 at 12:59 p.m. ET by Steve Gelsi

Cannabis legalization at the federal level won’t happen soon, analyst predicts, even as more states open up to adult-use market

TSNDF

0.63%

Jul. 25, 2023 at 7:52 a.m. ET by Steve Gelsi

New York cannabis board OK’s settlement in licensing suit brought by veterans

‘It’s very easy to get fooled’: Two cannabis rivals are raising awareness about fake-products scams

Canopy Growth hits snag with SEC over Canopy USA plan

Cresco Labs’ stock rises as revenue beats analyst estimate

Canopy Growth’s cash burn raises analyst concerns

Curaleaf and Canopy Growth miss third-quarter analyst marks while Green Thumb, Ascend Wellness, TerrAscend and Trulieve beat forecasts

Most Popular

What happens if a husband names someone other than his wife the beneficiary of an IRA?

Uber is officially an adult company, in large part due to CEO Dara Khosrowshahi

My father has dementia and ‘forgave’ my brother’s $200,000 house loan. The nursing-home notary said he was of sound mind. What can we do?

How to (legally) avoid taxes when selling a house

Dow near record high because traders are calling bluff on ‘higher-for-longer’ Fed

Gold futures soar to record close. Here’s what’s driving the rally.

Will George Santos still qualify for a pension and strolling around the House floor?

I was ‘financially set’ after my husband died. But my current adviser lost $500,000 over the last few years, and then a new adviser said my portfolio was ‘a mess’ and wants 1.25% to fix it. What’s my move?

Pimco's bond chief says investors need to prepare for a hard landing

My husband added my mother-in-law to the deed of our house 20 years ago. Now we’re getting divorced, and she wants one-third. Can I fight this?

More from Cannabis Watch

Bettering Co. takes aim at New York and New Jersey with premium edibles as legal-cannabis market grows slowly

Americans’ support for legalizing cannabis edges up to 70% and Ohio voters OK pot referendum, as cannabis stocks rise

Organigram’s stock soars as British American Tobacco invests $91.3 million

Ohio voters could legalize marijuana use next week, polls show

Cannabis companies hire Microsoft antitrust lawyer David Boies to sue U.S. government for federal pot prohibition

Tilray’s net loss narrows as revenue climbs to record

Glass House Brands charts contrarian course as ex-cop fights for release of cannabis convicts and eyes low-cost cultivation in California

Cannabis company Curaleaf applying to move listing to Toronto Stock Exchange in a move to boost visibility

Cannabis stocks rise as Senate committee OKs cannabis banking bill

Canopy Growth’s stock sustains rally as it draws praise for BioSteel exit

Canopy Growth’s BioSteel sports drink unit files for bankruptcy in a move to stem cash burn

Medical-cannabis companies blast New York for ‘clear course for failure’ in state pot-business rollout

Raw rolling papers founder looks to further elevate cannabis name celebrated in Wiz Khalifa song

HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain

HHS recommends rescheduling cannabis, and stocks in the sector rally

Canopy Growth selling Smiths Falls facility back to Hershey to generate about $39 million to pay down debt

TerrAscend says Morgan Stanley, BNY Mellon lift custody ban on cannabis for Toronto Stock Exchange listing

Corrected Canopy Growth beats analyst targets as its ‘asset-light’ strategy bears fruit, but Curaleaf’s miss weighs on pot stocks

Cannabis company Tilray rallies as it narrows its loss on a 20% boost to revenue

Cannabis legalization at the federal level won’t happen soon, analyst predicts, even as more states open up to adult-use market

No Recent Tickers

Corrected Canopy Growth beats analyst targets as its ‘asset-light’ strategy bears fruit, but Curaleaf’s miss weighs on pot stocks

Symbols

Private Companies

No Recent Tickers

Authors

Sections

Columns